An interventional study of Warmed Povidone-Iodine Skin Antisepsis and Room-Temperature Povidone-Iodine Skin Antisepsis in Coronary Artery Disease, Perioperative Care and Pain, sponsored by Zonguldak Bulent Ecevit University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Zonguldak Bulent Ecevit University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 138 studies in Coronary Artery Disease with a site in Turkey — 33 open to participants now, 42 under way, 4 of them phase 3. Coronary Artery Disease · Turkey.
Among the 138 studies in Coronary Artery Disease with a site in Turkey, this one is the 42nd largest by enrollment of the 72 interventional ones that give a count, is one of 19 that started in 2025, is one of 59 with no phase, and was the 138th registered.
4,863 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.
Browse Coronary Artery Disease studies →33 of the 138 studies in Coronary Artery Disease with a site in Turkey are open now. Recruiting first, the newest first:
Adiyaman University · Sites in Turkey
Ages 18+
Elzem SEN · Sites in Turkey
Ages 18–80
Elzem SEN · Sites in Turkey
Ages 18–80
TC Erciyes University · Sites in Turkey
Ages 18–50 · Women only
Uludag University · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 588 Coronary Artery Disease studies recruiting now, 402 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 38 take children under 18; 48 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
138 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 11 · Phase 4 1
First in 2004; this study’s year is marked. 19 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 64 is below the median of 124 across 3,010 interventional studies indexed under Coronary Artery Disease.
Median enrollment 70 across the 72 interventional studies, 167 across the 66 observational. Of the 83 that completed or were terminated, 10 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 138 have an industry lead sponsor. The 10 most frequent:
Zonguldak Bulent Ecevit University is the lead sponsor of 102 studies on the registry; 8 are open to participants now.
Zonguldak Bulent Ecevit University has 1 study filed under Coronary Artery Disease — fewer than ten, so there is no comparison to draw.
15 of the studies in Coronary Artery Disease with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07444697Kırıkkale University"Erectile Function After PCI in MI and Non-MI Patients" | 2026-11 |
| NCT07051473Istanbul University - CerrahpasaRelationship Between Coronary CT Angiography Findings and Prognosis Of Patients Undergoing PCI | 2026-12 |
| NCT07825376Abant Izzet Baysal UniversityBranching Scenario-Based Education in Coronary Artery Disease | 2026-12 |
| NCT07771127Uludag UniversityHEMOSTATİC PAD AND SANDBAG | 2026-12-30 |
| NCT07841847Kutahya Health Sciences UniversityEffects of Personalized Cardiac Rehabilitation on miRNAs and Biochemical Biomarkers in Patients With Coronary Artery Disease | 2026-12-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 138 studies in Coronary Artery Disease with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomised controlled trial investigated the effect of skin antisepsis performed with povidone-iodine warmed to 36°C, compared with room-temperature povidone-iodine, on perioperative comfort, pain intensity, and physiological parameters in patients aged 65 years and older undergoing elective coronary angiography. The study was conducted at the Coronary Angiography Unit of Zonguldak Atatürk State Hospital. Participants were randomly assigned to either the intervention group (warmed povidone-iodine at 36°C) or the control group (room-temperature povidone-iodine). Perioperative comfort was assessed using the Perioperative Comfort Questionnaire, pain intensity was measured using a Visual Analogue Scale, and physiological parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, body temperature, and peripheral oxygen saturation were recorded at four time points: before antisepsis, immediately after antisepsis, after local anaesthetic injection, and after vascular access.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Skin antisepsis was performed using 10% povidone-iodine solution warmed to 36°C using a solution warmer device prior to coronary angiography.
Other: Warmed Povidone-Iodine Skin Antisepsis
Skin antisepsis was performed using 10% povidone-iodine solution at room temperature (approximately 22-24°C) prior to coronary angiography.
Other: Room-Temperature Povidone-Iodine Skin Antisepsis
10% povidone-iodine solution was warmed to 36°C using a solution warmer device and applied to the inguinal region prior to coronary angiography. The intervention was performed by the researcher nurse immediately before the procedure.
10% povidone-iodine solution at room temperature (approximately 22-24°C) was applied to the inguinal region prior to coronary angiography. The intervention was performed by the researcher nurse immediately before the procedure.
Perioperative Comfort
Perioperative comfort was assessed using the Perioperative Comfort Questionnaire (PCQ). The scale consists of 13 items rated on a 5-point Likert scale, with higher scores indicating greater comfort.
Time frame: Assessed immediately after the coronary angiography procedure (approximately 30-45 minutes after baseline)
Pain Intensity
Pain intensity was measured using a Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst possible pain).
Time frame: Measured at four time points: before antisepsis (baseline), immediately after antisepsis, after local anaesthetic injection, and after vascular access
Systolic and Diastolic Blood Pressure
Systolic and diastolic blood pressure measured in mmHg using a standard sphygmomanometer.
Time frame: Measured at four time points: before antisepsis (baseline), immediately after antisepsis, after local anaesthetic injection, and after vascular access
Heart Rate
Heart rate measured in beats per minute using pulse oximetry.
Time frame: Measured at four time points: before antisepsis (baseline), immediately after antisepsis, after local anaesthetic injection, and after vascular access
Body Temperature
Body temperature measured in degrees Celsius using a tympanic thermometer.
Time frame: Measured at four time points: before antisepsis (baseline), immediately after antisepsis, after local anaesthetic injection, and after vascular access
Peripheral Oxygen Saturation
Peripheral oxygen saturation (SpO2) measured as a percentage using pulse oximetry.
Time frame: Measured at four time points: before antisepsis (baseline), immediately after antisepsis, after local anaesthetic injection, and after vascular access
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2025 to primary completion in Jan 2026, 3 months.
Of 754 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's 3 months is below that.
Counting every sponsor, half of 931 studies reached it within 30 months; a quarter within 15 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zonguldak Bulent Ecevit University →